NDA 205383, held by Interpharma Praha As. Iohexol.
As of Nov 16, 2026, NDA 205383 (Oraltag), held by Interpharma Praha As, was first approved by FDA on Mar 26, 2015, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 26, 2015 | Original applicationNew dosage form · Standard review | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Oraltag9.7GM/BOT · for solution;oral | Iohexol | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters